Stand up to beat diabetes: new study tests desk hack

NCT ID NCT05585190

Recruiting now Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a sit-stand desk at work can improve insulin sensitivity and reduce diabetes risk in 198 overweight, sedentary adults with prediabetes or other risk factors. Participants are randomly assigned to stand 2 or 3 hours per day at a sit-stand desk, or to a control group, for 6 months. Researchers will measure changes in insulin resistance, blood sugar, and other health markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sit-stand desk
What this could lead to: If it works, this could point toward a simple workplace change to help prevent or delay type 2 diabetes in at-risk adults.
What could go wrong: This is a relatively small, early-phase trial (198 participants) testing a behavioral intervention, so results may not apply broadly. The effect may be modest or require long-term adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome glucose intolerance Insulin Resistance metabolic syndrome X Motor Activity Obesity obesity disorder Overweight prediabetes syndrome Sedentary Behavior type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METABOLIC SYNDROME OBESITY PRE-DIABETES SEDENTARY BEHAVIOR

Contacts and locations

Locations

Medical College of Wisconsin
RECRUITING

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.